Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, cash reserves at Biosergen AB fell by 27.46m. Cash Flow from Financing totalled 5.30m or -- of revenues. In addition the company used 32.76m for operations while cash used for investing totalled .
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0557 |
---|---|
Tangible book value per share | 0.0557 |
More ▼
Balance sheet in SEKView more
Current ratio | 5.16 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼